US equities |
SPCX $166.77 ▲+4.91% NVDA $236.62 ▲+1.14% MU $1,064.26 ▼-0.99% TSLA $377.90 ▲+1.97% MSFT $526.38 ▲+1.71% SNDK $1,714.20 ▼-0.34% INTC $117.04 ▼-1.92% META $745.64 ▲+2.41%
FinancialContent

Articles published by Incyte and Escient Pharmaceuticals

News headline image
Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
From Incyte and Escient Pharmaceuticals
Via Business Wire
Tickers INCY